The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Machine-learning approaches in drug discovery: methods and applications
Abstract
During the past decade, virtual screening (VS) has evolved from traditional similarity searching, which utilizes single reference compounds, into an advanced application domain for data mining and machine-learning approaches, which require large and representative training-set compounds to learn robust decision rules. The explosive growth in the amount of public domain-available chemical and biological data has generated huge effort to design, analyze, and apply novel learning methodologies. Here, I focus on machine-learning techniques within the context of ligand-based VS (LBVS). In addition, I analyze several relevant VS studies from recent publications, providing a detailed view of the current state-of-the-art in this field and highlighting not only the problematic issues, but also the successes and opportunities for further advances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
The Nature of Statistical Learning Theory
Vapnik, V. N. (1995) · doi:10.1007/978-1-4757-2440-0 · Cited by 39,138
Neural Networks: A Comprehensive Foundation
Haykin, S. (1998) · Cited by 30,070
Wu, Y. (1999) · Technometrics · doi:10.1080/00401706.1999.10485951 · Cited by 27,221
(1992) · Cited by 23,431
A decision-theoretic generalization of on-line learning and an application to boosting
Freund, Y., & Schapire, R. E. (1997) · Journal of Computer and System Sciences · doi:10.1006/jcss.1997.1504 · Cited by 20,466
(2012) · Encyclopedia of the Sciences of Learning · doi:10.1007/978-1-4419-1428-6_5195 · Cited by 19,370
Breiman, L. (1996) · Machine Learning · doi:10.1007/bf00058655 · Cited by 16,325
The Nature of Statistical Learning Theory
Vapnik, V. N. (2000) · Springer eBooks · doi:10.1007/978-1-4757-3264-1 · Cited by 10,696
Russell, E. L., Chiang, L. H., & Braatz, R. D. (2000) · Advances in Industrial Control · doi:10.1007/978-1-4471-0409-4_3 · Cited by 7,862
Cited by
Automated exploration of the low-energy chemical space with fast quantum chemical methods
Pracht, P., Bohle, F., & Grimme, S. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp06869d · Cited by 2,363
Molecular Docking: Shifting Paradigms in Drug Discovery
Pinzi, L., & Rastelli, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184331 · Cited by 2,344
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“As a subset of AI, ML is a technique for coordinating VS for drug leads, which generally incorporates gathering a filtered set of compounds, containing known actives and inactive compounds to train a model [423, 424].”
MethodPredicting reaction performance in C–N cross-coupling using machine learning
Ahneman, D. T., Estrada, J. G., Lin, S., Dreher, S. D., & Doyle, A. G. (2018) · Science · doi:10.1126/science.aar5169 · Cited by 1,058
Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913
ADMET modeling approaches in drug discovery
Ferreira, L. L. G., & Andricopulo, A. D. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.015 · Cited by 825
Less is more: Sampling chemical space with active learning
Smith, J. S., Nebgen, B., Lubbers, N., Isayev, O., & Roitberg, A. E. (2018) · The Journal of Chemical Physics · doi:10.1063/1.5023802 · Cited by 811
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
Zhang, L., Tan, J., Han, D., & Zhu, H. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.010 · Cited by 760
Deep Learning in Drug Discovery
Gawehn, E., Hiss, J. A., & Schneider, G. (2016) · Molecular Informatics · doi:10.1002/minf.201501008 · Cited by 723
Rodríguez-Pérez, R., & Bajorath, J. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00314-0 · Cited by 718
Computational methods in drug discovery
Leelananda, S. P., & Lindert, S. (2016) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.12.267 · Cited by 639
In silico methods and tools for drug discovery
Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104851 · Cited by 607
Medical big data: promise and challenges
Lee, C. H., & Yoon, H.-J. (2017) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.2017.36.1.3 · Cited by 594
Deep neural networks for the evaluation and design of photonic devices
Jiang, J., Chen, M., & Fan, J. A. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-00260-1 · Cited by 551
Rodríguez-Pérez, R., & Bajorath, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01101 · Cited by 512
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Classification of Rockburst in Underground Projects: Comparison of Ten Supervised Learning Methods
Zhou, J., Li, X., & Mitri, H. S. (2016) · Journal of Computing in Civil Engineering · doi:10.1061/(asce)cp.1943-5487.0000553 · Cited by 443
Peptide Design Principles for Antimicrobial Applications
Torres, M. D. T., Sothiselvam, S., Lu, T. K., & de la Fuente-Nunez, C. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.12.015 · Cited by 438
Machine learning approaches and databases for prediction of drug–target interaction: a survey paper
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz157 · Cited by 429
Descriptors and their selection methods in QSAR analysis: paradigm for drug design
Danishuddin, & Khan, A. U. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.013 · Cited by 388
Deep learning in drug discovery: opportunities, challenges and future prospects
Lavecchia, A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.07.006 · Cited by 353
Self-citationZheng, L., Fan, J., & Mu, Y. (2019) · ACS Omega · doi:10.1021/acsomega.9b01997 · Cited by 338
Chen, C., & Gu, G. X. (2020) · Advanced Science · doi:10.1002/advs.201902607 · Cited by 335
Improving scoring-docking-screening powers of protein-ligand scoring functions using random forest
Wang, C., & Zhang, Y. (2017) · Journal of Computational Chemistry · doi:10.1002/jcc.24667 · Cited by 334
Identifying drug–target interactions based on graph convolutional network and deep neural network
Zhao, T., Hu, Y., Valsdottir, L. R., Zang, T., & Peng, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa044 · Cited by 332
Computational/in silico methods in drug target and lead prediction
Agamah, F. E., Mazandu, G. K., Hassan, R., Bope, C. D., Thomford, N. E., Ghansah, A., & Chimusa, E. R. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz103 · Cited by 328
Autonomous Discovery in the Chemical Sciences Part I: Progress
Coley, C. W., Eyke, N. S., & Jensen, K. F. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201909987 · Cited by 317
Machine learning for composite materials
Chen, C.-T., & Gu, G. X. (2019) · MRS Communications · doi:10.1557/mrc.2019.32 · Cited by 311
Synthetic organic chemistry driven by artificial intelligence
de Almeida, A. F., Moreira, R., & Rodrigues, T. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0124-0 · Cited by 303
A Structure-Based Platform for Predicting Chemical Reactivity
Sandfort, F., Strieth-Kalthoff, F., Kühnemund, M., Beecks, C., & Glorius, F. (2020) · Chem · doi:10.1016/j.chempr.2020.02.017 · Cited by 288
Bioactive Molecule Prediction Using Extreme Gradient Boosting
Babajide Mustapha, I., & Saeed, F. (2016) · Molecules · doi:10.3390/molecules21080983 · Cited by 278
The Light and Dark Sides of Virtual Screening: What Is There to Know?
Gimeno, A., Ojeda-Montes, M. J., Tomás-Hernández, S., Cereto-Massagué, A., Beltrán-Debón, R., Mulero, M., Pujadas, G., & Garcia-Vallvé, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061375 · Cited by 267
Taffese, W. Z., & Sistonen, E. (2017) · Automation in Construction · doi:10.1016/j.autcon.2017.01.016 · Cited by 255
Use of machine learning approaches for novel drug discovery
Lima, A. N., Philot, E. A., Trossini, G. H. G., Scott, L. P. B., Maltarollo, V. G., & Honorio, K. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1146250 · Cited by 254
Unleashing the power of generative AI in drug discovery
Gangwal, A., & Lavecchia, A. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103992 · Cited by 195
Self-citationMachine learning dihydrogen activation in the chemical space surrounding Vaska's complex
Friederich, P., dos Passos Gomes, G., De Bin, R., Aspuru-Guzik, A., & Balcells, D. (2020) · Chemical Science · doi:10.1039/d0sc00445f · Cited by 179
DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs
Li, F., Hu, Q., Zhang, X., Sun, R., Liu, Z., Wu, S., Tian, S., Ma, X., Dai, Z., Yang, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34807-3 · Cited by 159
“Over the past fewyears,the production of enormous, high-quality data in biological systems has accelerated the applications of arti fi cial intelligence (AI) approaches within the fi eld of drug discovery and development 39 – 44 .”
BackgroundKhan, P. M., & Roy, K. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1542428 · Cited by 113
Pastur-Romay, L., Cedrón, F., Pazos, A., & Porto-Pazos, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081313 · Cited by 109
Computational methods for prediction of in vitro effects of new chemical structures
Banerjee, P., Siramshetty, V. B., Drwal, M. N., & Preissner, R. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0162-2 · Cited by 60
Machine learning meets quantum foundations: A brief survey
Bharti, K., Haug, T., Vedral, V., & Kwek, L.-C. (2020) · AVS Quantum Science · doi:10.1116/5.0007529 · Cited by 59
Dhamodharan, G., & Mohan, C. G. (2022) · Molecular Diversity · doi:10.1007/s11030-021-10282-8 · Cited by 56
A new paradigm for applying deep learning to protein–ligand interaction prediction
Wang, Z., Wang, S., Li, Y., Guo, J., Wei, Y., Mu, Y., Zheng, L., & Li, W. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae145 · Cited by 41
Integrating Machine Learning to Undergraduate Engineering Curricula Through Project-Based Learning
Huang, L. (2019) · 2019 IEEE Frontiers in Education Conference (FIE) · doi:10.1109/fie43999.2019.9028688 · Cited by 14
“More and more real-world engineering problems have been or are being reformulated and solved using this data-driven approach, which has been shown to outperform traditional solution approaches in many applicationsn[1-4].”
BackgroundAABBA Graph Kernel: Atom-Atom, Bond-Bond, and Bond-Atom Autocorrelations for Machine Learning
Morán-González, L., Betten, J. E., Kneiding, H., & Balcells, D. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01583 · Cited by 12
Using Stochastic Computing for Virtual Screening Acceleration
Frasser, C. F., de Benito, C., Skibinsky-Gitlin, E. S., Canals, V., Font-Rosselló, J., Roca, M., Ballester, P. J., & Rosselló, J. L. (2021) · Electronics · doi:10.3390/electronics10232981 · Cited by 3
Uchikawa, K., Furui, K., & Ohue, M. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102110 · Cited by 1
Metadata
- Authors
- Lavecchia, A.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 20
- Issue
- 3
- Pages
- 318-331
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2053717624
- Cited by
- 784
- References
- 139
- FWCI
- 23.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.